Precision Medicine is a Continuum: Perspectives on Navigation and Partnerships

One Nucleus in association with Covance presents a Life Science Leadership series session on Precision Medicine

Precision Medicine is a Continuum: Perspectives on Navigation and Partnerships

• Leveraging Biomarker Expertise    
• Trends in Genomics and applications for Immuno-Oncology     
• Engaging with Pharma Partners     
• The Path from Exploratory Biomarker to Companion Diagnostic  
• What differentiates a good lab/ CRO                                          

Programme:

10:30 - Registration Opens

11:00 - Welcome and Overview
Steve Anderson, CSO, Covance

11:15 - Precision Medicine and Companion Diagnostics: Innovation focused on patients
Mark Fidock, Head of Precision Medicine Laboratories, AstraZeneca

12:00 - Trends in Genomics and their Application
Steve Anderson
Svetlana Nikic, Market Development Manager in EMEA, Illumina
Jonathan Moore, CSO, Horizon Discovery Group

13:00 -  Lunch

14:00 -  Tools and Approaches for Integrating and Applying Complex Data

Moderated by
Adam Baumgart, Senior Director Monitoring and Data Flow Optimisation, Covance
Günter Schmidt, VP of Research, Definiens
Mike Romanos, CEO, Microbiotica

15:00 -  The Path from Biomarker to Companion Diagnostic
Mark Roberts, Senior Scientific Director, Covance

15:30 -  Break

16:00 -  Panel Discussion: How to Engage with Partners

Moderated by
Steve Anderson, CSO, Covance

Panellists:
Phil L’Huillier, Head of Innovation Hub London, MSD
Peter Pack, CEO, Crescendo Biologics
Rene van der Merwe, Vice-President, Respiratory Clinical, MedImmune
Rochana Wickramasinghe, Director of Oncology Evaluation, AstraZeneca

17:00 -  Closing Remarks

17:15 -  Networking over drinks and canapes

18:30 -  Close

Prices
Gold and Academic - £75 + VAT
Silver - £175 + VAT
Non-member - £275 + VAT